Wyatt Completes Acquisition of the Assets of Proterion Corporation
News Dec 01, 2004
Wyatt Technology has completed the acquisition of the assets of Proterion Corporation (formerly Protein Solutions). Proterion was a supplier of computer-controlled life sciences instrumentation for particle sizing and biomolecular characterization of protein molecules for the pharmaceutical and biotechnology markets. Headquartered in Piscataway, New Jersey, Proterion has over 1000 systems installed worldwide.
The company's manufacturing facility, based in High Wycombe, United Kingdom, as well as assets from the New Jersey offices, will be transferred to Wyatt Technology's headquarters in Santa Barbara. Several staff from the UK and New Jersey offices are also expected to join Wyatt Technology shortly.
"The Proterion acquisition brings us world-class products and deep industry expertise," comments Geof Wyatt, President of Wyatt Technology. "The addition of Proterion's DynaPro™ (Protein Solutions™) product lines broadens and strengthens the array of solutions that Wyatt is able to offer its customers. In key applications such as protein crystallography, we should be the 'best of breed'.
As laboratories increasingly rely on light scattering for absolute characterization, Wyatt is strategically positioned to offer a broad portfolio of solutions. We have the in-house expertise and resources required to be successful in this market."
As genome editing technologies advance toward clinical therapies, they are raising hopes of a completely new way to treat disease. However, challenges need to be addressed before potential treatments can be widely used in patients. To tackle these challenges, the National Institutes of Health has launched the Somatic Cell Genome Editing program, which has awarded multiple grants including more than $3.6 million to assess the safety of genome editing in human cells and tissues.